Alerts will be sent to your verified email
Verify EmailTITANBIO
5
10
20
Balance sheet of Titan Bio-Tech is strong.
It shouldn't have solvency or liquidity issues.
Yes, The net debt of Titan Bio-Tech is increasing.
Latest net debt of Titan Bio-Tech is ₹4.49 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹8.94 Crs.
No, profit is decreasing.
The profit of Titan Bio-Tech is ₹20.59 Crs for TTM, ₹21.53 Crs for Mar 2025 and ₹24.85 Crs for Mar 2024.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Titan Bio-Tech latest dividend payout ratio is 7.68% and 3yr average dividend payout ratio is 6.77%
Companies resources are majorly tied in miscellaneous assets